Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

PIK bought a part of the territory of the wine and cognac enterprise

9/25/23 PIKK

Tatneft will start using unmanned light trucks Evocargo

9/25/23 TATN

Polymetal reported for 6 months of 2023

9/25/23 POLY

Russneft in the first half of the year reduced oil production by 3.8%

9/22/23 RNFT

Gazprom Neft launched a new primary refining complex at the Omsk Refinery

9/22/23 SIBN

Polymetal to relocate Pacific MMC from Sovgavan to Kazakhstan

9/22/23 POLY

Fix Price launched delivery of goods via Yandex services

9/22/23 FIXP

Gazprombank and Mechel decided to reach an amicable agreement

9/22/23 MTLR

RuStore plans to increase its monthly audience to 25 mln by the end of the year

9/22/23 VKCO

Tatneft shareholders failed to approve dividends

9/22/23 TATN